EAN 2016 Peter Goadsby Interview
Peter Goadsby discusses the rationale for using CGRP antibodies in the treatment of migraine and the study findings so far.
Peter Goadsby discusses the rationale for using CGRP antibodies in the treatment of migraine and the study findings so far.